Roswell Biotechnologies

Roswell Biotechnologies Employees

10 people indexed:

Barry Merriman

CSO & CoFounder

d338x.d2vqzzvk@14zqf77ppjf393.k9p Sign up to see email

95q9d.5jv5dd65@pq0qzqfd7060gx.2x4 Sign up to see email
Bryan Rice

Head of Silicon Integration & Manufacturing Fellow

k248z.5zz6@9qf7u782z0zzdv.dg8 Sign up to see email

39u99.9fxp@dzq5p996g73g6k.xz0 Sign up to see email
Carl W. Fuller

Head of Roswell Innovation Lab

2y5p.5.jz41xx@94qv5yk1z152jz.32d Sign up to see email

d162.6.d1q02j@9zp6yjqk5qpyx6.qqd Sign up to see email
Dan Salehi

Head of Intellectual Property

j12.27fffk@8u8g9uy2f6g7q7.v4k Sign up to see email

5pu.357qpg@y4vq8u4k4p3j2k.2z3 Sign up to see email
Isabel Sauerbrey

Head of IT and Operations

zd1z72.9gn5768q9@3jxk48vkj4p55d.nd2 Sign up to see email

fgfzq6.0fz88j0ff@7kpp0n0z0g5xz0.ndf Sign up to see email
Jarrod Panza

JD Head of Corporate Development

08qqqx.k9435@45f1x8u90ygfxx.gq4 Sign up to see email

6q5v55.v9f0u@66xyq760k0yv2g.8x6 Sign up to see email
John Tompkins

Head of Product Commercialization

7u4y.qa7x3497@09zv3zf4zxzg56.6z7 Sign up to see email

5g86.dfu34x2g@ff05vuxvxv5616.18v Sign up to see email
Mike Nguyen

Head of Systems Integration

1320.0xa201@975pd317aad817.a9j Sign up to see email

4d35.38ja1j@f8v50v691zdjaz.0f7 Sign up to see email
Paul Mola

President, CEO & Founder

5y4j.g9z8@x6kk27kkjjn3nx.jfy Sign up to see email

288q.121v@2f3g9g67gfvjyx.n1x Sign up to see email
Seth Stern

Vice President Core Technology R&D

19aj.8xq6j@87aaaxy17p93pd.fzj Sign up to see email

6uaj.vk5a7@3g9za0gk85xdfx.085 Sign up to see email

Roswell Biotechnologies Company Information

Roswell Biotechnologies, headquartered in San Diego, California, developed the world’s first molecular electronics chip, the Roswell ME Chip. This innovative chip integrates single molecules as electrical sensor elements on standard semiconductor chips, allowing for precise electronic measurement at the single-molecule level. The Roswell ME Chip has applications in basic discovery, translational research, precision diagnostics, whole-genome sequencing, and environmental surveillance. The company offers a versatile platform technology that can sense a multitude of molecules on one chip, catering to scientific research, clinical, industrial, and consumer fields. Roswell Biotechnologies secured $32 million in a Series A financing round to further develop and commercialize its technology. Additionally, the company was awarded a government contract for DNA digital data storage, utilizing its molecular electronics technology for next-generation data storage solutions. The Roswell ME Platform aims to integrate genomics, transcriptomics, epigenomics, proteomics, and metabolomics on a single platform, transforming health and scientific research. The scalability of its molecular electronics chip was demonstrated in a peer-reviewed paper, highlighting its potential for broad deployment in various markets.

Report inaccurate information